Distribution of lung perfusion scintigraphy findings in pregnant women with suspected pulmonary embolism

Document Type : Original Article

Authors

1 Preclinical Lab, Core Facility, Kermanshah University of Medical Sciences, Kermanshah, Iran

2 Department of Medical Physics, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran

3 Department of Biostatistics, School of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran

4 Nuclear Medicine Department, Kermanshah University of Medical Sciences, Kermanshah, Iran

Abstract

Introduction: Pulmonary embolism (PE) is a potentially life-threatening condition and a leading cause of maternal mortality. Imaging plays a central role in the evaluation of suspected PE during pregnancy; however, concerns regarding radiation exposure and diagnostic yield remain. Lung perfusion scintigraphy is frequently used in this setting, yet data on the distribution of scan outcomes in pregnant patients are limited.
Methods: In this retrospective study, all pregnant women who underwent perfusion-only lung scintigraphy for suspected PE at a single tertiary center between May 2021 and January 2023 were included. Perfusion scans were performed using low-dose Tc-99m macroaggregated albumin ([99mTc]Tc-MAA))and interpreted independently by two nuclear medicine physicians according to PISAPED criteria. Scan results were classified as normal or high probability for PE.
Results: A total of 74 pregnant women were evaluated. The mean maternal age was approximately 30 years, and most patients were in the third trimester of pregnancy (75%). Normal perfusion scans were observed in 70 patients (94.5%), while 4 patients (5.5%) demonstrated high-probability findings for PE. No nondiagnostic scans were identified. All high-probability cases showed segmental or wedge-shaped perfusion defects consistent with PE.
Conclusion: Most pregnant women referred for lung perfusion scintigraphy for suspected PE had normal results, indicating a low prevalence of confirmed disease despite frequent clinical suspicion. Perfusion-only lung scintigraphy, when interpreted using PISAPED criteria, provides definitive results with a high normalcy rate in this population. These findings highlight the importance of optimizing clinical selection strategies to reduce unnecessary imaging and radiation exposure during pregnancy.

Keywords

Main Subjects


  1. Uchikova EH, Ledjev II. Changes in haemostasis during normal pregnancy. Eur J Obstet Gynecol Reprod Biol. 2005 Apr 1;119(2):185-8.
  2. Marik PE. Venous thromboembolism in pregnancy. Clin Chest Med. 2010 Dec;31(4):731-40.
  3. Quiroz R, Kucher N, Zou KH, Kipfmueller F, Costello P, Goldhaber SZ, Schoepf UJ. Clinical validity of a negative computed tomography scan in patients with suspected pulmonary embolism: a systematic review. JAMA. 2005 Apr 27;293(16):2012-7.
  4. Mos IC, Klok FA, Kroft LJ, DE Roos A, Dekkers OM, Huisman MV. Safety of ruling out acute pulmonary embolism by normal computed tomography pulmonary angiography in patients with an indication for computed tomography: systematic review and meta-analysis. J Thromb Haemost. 2009 Sep;7(9):1491-8.
  5. Nijkeuter M, Ginsberg JS, Huisman MV. Diagnosis of deep vein thrombosis and pulmonary embolism in pregnancy: a systematic review. J Thromb Haemost. 2006 Mar;4(3):496-500.
  6. Einstein AJ, Henzlova MJ, Rajagopalan S. Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography. JAMA. 2007 Jul 18;298(3):317-23.
  7. Shellock FG, Kanal E. Policies, guidelines, and recommendations for MR imaging safety and patient management. SMRI Safety Committee. J Magn Reson Imaging. 1991 Jan-Feb;1(1):97-101.
  8. Oudkerk M, van Beek EJ, Wielopolski P, van Ooijen PM, Brouwers-Kuyper EM, Bongaerts AH, Berghout A. Comparison of contrast-enhanced magnetic resonance angiography and conventional pulmonary angiography for the diagnosis of pulmonary embolism: a prospective study. Lancet. 2002 May 11;359(9318):1643-7.
  9. Tremblay E, Thérasse E, Thomassin-Naggara I, Trop I. Quality initiatives: guidelines for use of medical imaging during pregnancy and lactation. Radiographics. 2012 May-Jun;32(3):897-911.
  10. Kluge A, Müller C, Hansel J, Gerriets T, Bachmann G. Real-time MR with TrueFISP for the detection of acute pulmonary embolism: initial clinical experience. Eur Radiol. 2004 Apr;14(4):709-18.
  11. Bajc M, Neilly JB, Miniati M, Schuemichen C, Meignan M, Jonson B; EANM Committee. EANM guidelines for ventilation/perfusion scintigraphy : Part 1. Pulmonary imaging with ventilation/perfusion single photon emission tomography. Eur J Nucl Med Mol Imaging. 2009 Aug;36(8):1356-70.
  12. van Mens TE, Scheres LJ, de Jong PG, Leeflang MM, Nijkeuter M, Middeldorp S. Imaging for the exclusion of pulmonary embolism in pregnancy. Cochrane Database Syst Rev. 2017 Jan 26;1(1):CD011053.
  13. Sostman HD, Stein PD, Gottschalk A, Matta F, Hull R, Goodman L. Acute pulmonary embolism: sensitivity and specificity of ventilation-perfusion scintigraphy in PIOPED II study. Radiology. 2008 Mar;246(3):941-6.
  14. Goldberg SN, Richardson DD, Palmer EL, Scott JA. Pleural effusion and ventilation/perfusion scan interpretation for acute pulmonary embolus. J Nucl Med. 1996 Aug;37(8):1310-3.
  15. Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs JS, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M; Task Force for the Diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014 Nov 14;35(43):3033-69, 3069a-3069k.
  16. Hurwitz LM, Yoshizumi TT, Reiman RE, Paulson EK, Frush DP, Nguyen GT, Toncheva GI, Goodman PC. Radiation dose to the female breast from 16-MDCT body protocols. AJR Am J Roentgenol. 2006 Jun;186(6):1718-22.
  17. Doshi SK, Negus IS, Oduko JM. Fetal radiation dose from CT pulmonary angiography in late pregnancy: a phantom study. Br J Radiol. 2008 Aug;81(968):653-8.
  18. Nijkeuter M, Geleijns J, De Roos A, Meinders AE, Huisman MV. Diagnosing pulmonary embolism in pregnancy: rationalizing fetal radiation exposure in radiological procedures. J Thromb Haemost. 2004 Oct;2(10):1857-8.
  19. Hendee WR, Edwards FM. ALARA and an integrated approach to radiation protection. Semin Nucl Med. 1986 Apr;16(2):142-50.
  20. Bourjeily G, Paidas M, Khalil H, Rosene-Montella K, Rodger M. Pulmonary embolism in pregnancy. Lancet. 2010 Feb 6;375(9713):500-12.
  21. Abele JT, Sunner P. The clinical utility of a diagnostic imaging algorithm incorporating low-dose perfusion scans in the evaluation of pregnant patients with clinically suspected pulmonary embolism. Clin Nucl Med. 2013 Jan;38(1):29-32.
  22. Cutts BA, Tran HA, Merriman E, Nandurkar D, Soo G, DasGupta D, Prassannan N, Hunt BJ. The utility of the Wells clinical prediction model and ventilation-perfusion scanning for pulmonary embolism diagnosis in pregnancy. Blood Coagul Fibrinolysis. 2014 Jun;25(4):375-8.
  23. Chan WS, Lee A, Spencer FA, Crowther M, Rodger M, Ramsay T, Ginsberg JS. Predicting deep venous thrombosis in pregnancy: out in "LEFt" field? Ann Intern Med. 2009 Jul 21;151(2):85-92.
  24. da Silva R, Shah M, Freeman LM. Ventilation-perfusion (V/Q) lung scintigraphy: a long journey to a renewed position of prominence in diagnosing pulmonary embolism. Clin Transl Imaging. 2014 Oct;2(5):369-78.
  25. Niemann T, Nicolas G, Roser HW, Müller-Brand J, Bongartz G. Imaging for suspected pulmonary embolism in pregnancy-what about the fetal dose? A comprehensive review of the literature. Insights Imaging. 2010 Nov;1(5-6):361-372.
  26. Nakamura Y, Kangai Y, Sato S, Shibata S, Abe T, Mimura H, Inubushi M. [Impact of residual radioactivity rate of 99mTc-macro aggregated albumin (MAA) in syringes and administration routes with a focus on pediatric nuclear medicine examinations]. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2023 Aug 20;79(8):802-809. Japanese.
  27. Zhu A, Reeder SB, Johnson KM, Nguyen SM, Fain SB, Bird IM, Golos TG, Wieben O, Shah DM, Hernando D. Quantitative ferumoxytol-enhanced MRI in pregnancy: A feasibility study in the nonhuman primate. Magn Reson Imaging. 2020 Jan;65:100-108.
  28. Bak SH, Kim C, Kim CH, Ohno Y, Lee HY. Magnetic resonance imaging for lung cancer: a state-of-the-art review. Precision and Future Medicine. 2022 Feb 28;6(1):49-77.
  29. Sedgwick P. Ecological studies: advantages and disadvantages. BMJ. 2014 May 2;348:g2979.
  30. Lasch F, Karch A, Koch A, Derlin T, Voskrebenzev A, Alsady TM, Hoeper MM, Gall H, Roller F, Harth S, Steiner D, Krombach G, Ghofrani HA, Rengier F, Heußel CP, Grünig E, Beitzke D, Hacker M, Lang IM, Behr J, Bartenstein P, Dinkel J, Schmidt KH, Kreitner KF, Frauenfelder T, Ulrich S, Hamer OW, Pfeifer M, Johns CS, Kiely DG, Swift AJ, Wild J, Vogel-Claussen J. Comparison of MRI and VQ-SPECT as a screening test for patients with suspected CTEPH: CHANGE-MRI study design and rationale. Front Cardiovasc Med. 2020 Apr 9;7:51.